Lipoprotein Apheresis Shows Durable Impact on CV Outcomes
Lipoprotein apheresis (LA) is a safe and effective treatment for very-high-risk dyslipidemia, sustai...
FDA Okays New Indication for Alirocumab in Homozygous FH
The US Food and Drug Administration has approved a...